Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06424522

Low Anterior Resection Syndrome: Retrograde Enema Program versus Medical Management for Rectal Cancer Patients

Led by Ohio State University Comprehensive Cancer Center · Updated on 2026-04-21

80

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating treatments for low anterior resection syndrome (LARS), a condition affecting bowel function after part of the rectum is surgically removed in rectal cancer patients. LARS can cause symptoms like urgency, incontinence, frequent bowel movements, constipation, and incomplete emptying. This trial compares a bowel management program using a retrograde rectal enema (RRE) with standard medical management to determine which approach better manages LARS symptoms. Participants are randomly assigned to one of two groups. One group receives a combination of medical management—including fiber, loperamide hydrochloride, and pelvic floor physical therapy—plus a self-administered RRE enema regimen for one year. The other group receives medical management alone for one year and may be referred for surgery if symptoms persist. Abdominal x-rays may be performed during the trial for participants using the RRE. Throughout the study, participants will be assessed using a validated LARS scoring tool and surveys to measure fecal incontinence and patient satisfaction up to one year after treatment starts. Follow-up visits occur at one month, three months, and one year after completing the intervention. The trial aims to evaluate effectiveness, feasibility, and symptom control of the treatments over this period.

CONDITIONS

Brief Title

A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Diagnosed with moderate to severe low anterior resection syndrome (LARS)
  • History of rectal cancer treated with proctectomy
  • Has undergone standard medical management without symptom improvement for 3 to 6 months
Not Eligible

You will not qualify if you...

  • Significant rectal strictures requiring surgery; minor strictures allowed if catheter can pass after exam
  • Chemotherapy or radiation therapy within the last 6 months
  • Current colorectal cancer diagnosis
  • Recurrent colorectal cancer
  • Colorectal surgery within the last 3 months
  • Progressive neurological disease
  • Active or recurrent sacral infection
  • Under 18 years old
  • Active sacral nerve stimulator device
  • Pregnant or planning pregnancy during treatment
  • Altered mental status or disability affecting enema self-administration
  • Any factor making the participant unsuitable, such as transportation issues or unreliable communication

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 1 year

Participants are assigned to one of two treatment groups for 1 year: Group I uses a bowel management program combining medical management with a retrograde rectal enema system to self-administer enemas; Group II receives medical management alone including fiber, loperamide hydrochloride, and pelvic floor physical therapy. Participants may undergo abdominal x-rays during treatment.

Visits as needed for medical management and abdominal x-rays during treatment

Follow-up

Duration - 1 year

After completing treatment, participants are followed up at 1 month, 3 months, and 1 year to assess outcomes and satisfaction.

3 visits (in-person) at 1 month, 3 months, and 1 year post-treatment

Trial Site Locations

Total: 1 location

1

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, United States, 43210

Actively Recruiting

Loading map...

Research Team

T

The Ohio State Comprehensive Cancer Center

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Similar Trials

Antegrade Intestinal Fluid Reinfusion Versus Water Infusion ...

Low Anterior Resection Syndrome

Actively Recruiting

1 location

Assessment of Quality of Life After Low Anterior Resection o...

Ovarian Cancer

Actively Recruiting

1 location

Comparison of Postoperative Anal Function Between Parks and ...

Rectal Neoplasms

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here